IGKV1D-22 and atherosclerosis: S100A8/A9 plays a critical dual role in cardiovascular inflammation and repair, emerging not only as a biomarker but also as a promising therapeutic target in ASCVD, HF, and cardiac arrhythmogenesis, with potential applications for anti-inflammatory intervention.